-
1
-
-
33749445317
-
Ranibizumab for neovascular age-related macular degeneration
-
DOI 10.1056/NEJMoa054481
-
P.J. Rosenfeld, D.M. Brown, J.S. Heier Ranibizumab for neovascular age-related macular degeneration N Engl J Med 355 14 2006 1419 1431 (Pubitemid 44511557)
-
(2006)
New England Journal of Medicine
, vol.355
, Issue.14
, pp. 1419-1431
-
-
Rosenfeld, P.J.1
Brown, D.M.2
Heier, J.S.3
Boyer, D.S.4
Kaiser, P.K.5
Chung, C.Y.6
Kim, R.Y.7
-
2
-
-
33749451356
-
Ranibizumab versus verteporfin for neovascular age-related macular degeneration
-
DOI 10.1056/NEJMoa062655
-
D.M. Brown, P.K. Kaiser, M. Michels Ranibizumab versus verteporfin for neovascular age-related macular degeneration N Engl J Med 355 14 2006 1432 1444 (Pubitemid 44511558)
-
(2006)
New England Journal of Medicine
, vol.355
, Issue.14
, pp. 1432-1444
-
-
Brown, D.M.1
Kaiser, P.K.2
Michels, M.3
Soubrane, G.4
Heier, J.S.5
Kim, R.Y.6
Sy, J.P.7
Schneider, S.8
-
3
-
-
57949094834
-
Ranibizumab versus verteporfin photodynamic therapy for neovascular age-related macular degeneration: Two-year results of the ANCHOR study
-
e5
-
D.M. Brown, M. Michels, P.K. Kaiser, J.S. Heier, J.P. Sy, T. Ianchulev Ranibizumab versus verteporfin photodynamic therapy for neovascular age-related macular degeneration: Two-year results of the ANCHOR study Ophthalmology 116 1 2009 57 65 e5
-
(2009)
Ophthalmology
, vol.116
, Issue.1
, pp. 57-65
-
-
Brown, D.M.1
Michels, M.2
Kaiser, P.K.3
Heier, J.S.4
Sy, J.P.5
Ianchulev, T.6
-
4
-
-
33644502828
-
Intravitreal bevacizumab (Avastin) for neovascular age-related macular degeneration
-
R.L. Avery, D.J. Pieramici, M.D. Rabena, A.A. Castellarin, M.A. Nasir, M.J. Giust Intravitreal bevacizumab (Avastin) for neovascular age-related macular degeneration Ophthalmology 113 3 2006 363 372
-
(2006)
Ophthalmology
, vol.113
, Issue.3
, pp. 363-372
-
-
Avery, R.L.1
Pieramici, D.J.2
Rabena, M.D.3
Castellarin, A.A.4
Nasir, M.A.5
Giust, M.J.6
-
5
-
-
33745091547
-
Intravitreal bevacizumab treatment of choroidal neovascularization secondary to age-related macular degeneration
-
DOI 10.1097/00006982-200604000-00001, PII 0000698220060400000001
-
R.F. Spaide, K. Laud, H.F. Fine Intravitreal bevacizumab treatment of choroidal neovascularization secondary to age-related macular degeneration Retina 26 4 2006 383 390 (Pubitemid 44197628)
-
(2006)
Retina
, vol.26
, Issue.4
, pp. 383-390
-
-
Spaide, R.F.1
Laud, K.2
Fine, H.F.3
Klancnik Jr., J.M.4
Meyerle, C.B.5
Yannuzzi, L.A.6
Sorenson, J.7
Slakter, J.8
Fisher, Y.L.9
Cooney, M.J.10
-
6
-
-
33745782355
-
Short-term safety and efficacy of intravitreal bevacizumab (Avastin) for neovascular age-related macular degeneration
-
DOI 10.1097/01.iae.0000225766.75009.3a, PII 0000698220060500000002
-
R.M. Rich, P.J. Rosenfeld, C.A. Puliafito Short-term safety and efficacy of intravitreal bevacizumab (Avastin) for neovascular age-related macular degeneration Retina 26 5 2006 495 511 (Pubitemid 44620390)
-
(2006)
Retina
, vol.26
, Issue.5
, pp. 495-511
-
-
Rich, R.M.1
Rosenfeld, P.J.2
Puliafito, C.A.3
Dubovy, S.R.4
Davis, J.L.5
Flynn, H.W.6
Gonzalez, S.7
Feuer, W.J.8
Lin, R.C.9
Lalwani, G.A.10
Nguyen, J.K.11
Kumar, G.12
-
7
-
-
38349122535
-
Intravitreal bevacizumab for treatment of neovascular age-related macular degeneration: A one-year prospective study
-
Z.F. Bashshur, Z.A. Haddad, A. Schakal, R.F. Jaafar, M. Saab, B.N. Noureddin Intravitreal bevacizumab for treatment of neovascular age-related macular degeneration: a one-year prospective study Am J Ophthalmol 145 2 2008 249 256
-
(2008)
Am J Ophthalmol
, vol.145
, Issue.2
, pp. 249-256
-
-
Bashshur, Z.F.1
Haddad, Z.A.2
Schakal, A.3
Jaafar, R.F.4
Saab, M.5
Noureddin, B.N.6
-
8
-
-
79956218863
-
Ranibizumab and bevacizumab for neovascular age-related macular degeneration
-
D.F. Martin, M.G. Maguire, G.S. Ying, J.E. Grunwald, S.L. Fine, G.J. Jaffe Ranibizumab and bevacizumab for neovascular age-related macular degeneration N Engl J Med 364 20 2011 1897 1908
-
(2011)
N Engl J Med
, vol.364
, Issue.20
, pp. 1897-1908
-
-
Martin, D.F.1
Maguire, M.G.2
Ying, G.S.3
Grunwald, J.E.4
Fine, S.L.5
Jaffe, G.J.6
-
9
-
-
33846586501
-
Subgroup Analysis of the MARINA Study of Ranibizumab in Neovascular Age-Related Macular Degeneration
-
DOI 10.1016/j.ophtha.2006.10.045, PII S0161642006014849
-
D.S. Boyer, A.N. Antoszyk, C.C. Awh, R.B. Bhisitkul, H. Shapiro, N.R. Acharya Subgroup analysis of the MARINA study of ranibizumab in neovascular age-related macular degeneration Ophthalmology 114 2 2007 246 252 (Pubitemid 46172497)
-
(2007)
Ophthalmology
, vol.114
, Issue.2
, pp. 246-252
-
-
Boyer, D.S.1
Antoszyk, A.N.2
Awh, C.C.3
Bhisitkul, R.B.4
Shapiro, H.5
Acharya, N.R.6
-
10
-
-
36249002808
-
Ranibizumab for predominantly classic neovascular age-related macular degeneration: subgroup analysis of first-year ANCHOR results
-
P.K. Kaiser, D.M. Brown, K. Zhang Ranibizumab for predominantly classic neovascular age-related macular degeneration: subgroup analysis of first-year ANCHOR results Am J Ophthalmol 144 6 2007 850 857
-
(2007)
Am J Ophthalmol
, vol.144
, Issue.6
, pp. 850-857
-
-
Kaiser, P.K.1
Brown, D.M.2
Zhang, K.3
-
11
-
-
60149107965
-
Delay in treating age-related macular degeneration in Spain is associated with progressive vision loss
-
233
-
L. Arias, F. Armada, J. Donate Delay in treating age-related macular degeneration in Spain is associated with progressive vision loss Eye (Lond) 23 2 2009 326 233
-
(2009)
Eye (Lond)
, vol.23
, Issue.2
, pp. 326
-
-
Arias, L.1
Armada, F.2
Donate, J.3
-
12
-
-
70349261111
-
Time between symptom onset and assessment in age-related macular degeneration with subfoveal choroidal neovascularization
-
R. Schalnus, C.H. Meyer, C. Kuhli-Hattenbach, M. Luchtenberg Time between symptom onset and assessment in age-related macular degeneration with subfoveal choroidal neovascularization Ophthalmologica 224 3 2009 176 182
-
(2009)
Ophthalmologica
, vol.224
, Issue.3
, pp. 176-182
-
-
Schalnus, R.1
Meyer, C.H.2
Kuhli-Hattenbach, C.3
Luchtenberg, M.4
-
13
-
-
75149116508
-
Intravitreal bevacizumab and ranibizumab for age-related macular degeneration a multicenter, retrospective study
-
Fong DS, Custis P, Howes J, Hsu JW. Intravitreal bevacizumab and ranibizumab for age-related macular degeneration a multicenter, retrospective study. Ophthalmology; 117(2):298302.
-
Ophthalmology
, vol.117
, Issue.2
, pp. 298302
-
-
Fong, D.S.1
-
14
-
-
70449622757
-
Bevacizumab vs ranibizumab for age-related macular degeneration: early results of a prospective double-masked, randomized clinical trial
-
e1
-
M.L. Subramanian, S. Ness, G. Abedi Bevacizumab vs ranibizumab for age-related macular degeneration: early results of a prospective double-masked, randomized clinical trial Am J Ophthalmol 148 6 2009 875 882 e1
-
(2009)
Am J Ophthalmol
, vol.148
, Issue.6
, pp. 875-882
-
-
Subramanian, M.L.1
Ness, S.2
Abedi, G.3
|